BSC
JAZZ icon

BOLTON SECURITIES CORPORATION’s Jazz Pharmaceuticals JAZZ Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Buy
+580
New +$101K 0.01% 994
2025
Q3 		$6.59K Buy
+50
New +$6K ﹤0.01% 1641
2025
Q1 		$52.6K Buy
+424
New +$55.3K ﹤0.01% 1032

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's JAZZ Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 580 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #994 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in JAZZ as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in JAZZ in Q1 2025 and has held it in 3 quarters since. 581 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 580 shares of Jazz Pharmaceuticals worth $110K as of Q1 2026.
  • Jazz Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #994 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 581 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.